Venture • Life Science

Greer Capital Advisors Invests In PNP Therapeutics

On July 6, 2007, private equity firm Greer Capital Advisors invested in life science company PNP Therapeutics

Investment Context
  • This is Greer Capital Advisors’ 4th transaction in the Life Science sector.
  • This is Greer Capital Advisors’ 6th transaction in the United States.
  • This is Greer Capital Advisors’ 3rd transaction in Alabama.

Explore All 557 Venture Life Science Deals - Search the Database Free


Investment Summary

Date July 6, 2007
Target PNP Therapeutics
Sector Life Science
Investor(s) Greer Capital Advisors
Deal Type Venture

Target Company

PNP Therapeutics

Birmingham, Alabama, United States
PNP Therapeutics is an operator of clinical-stage, a biopharmaceutical company engaged in the development of a platform technology and proprietary products for the treatment of cancer. PNP Therapeutics is based in Birmingham, Alabama.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

Greer Capital Advisors

Mountain Brook, Alabama, United States

Investor


Category Private Equity Firm
Founded 2002
Size Small
Type Sector Focused
DESCRIPTION

Greer Capital Advisors (GCA) is a specialized, heathcare focused private equity firm that targets investments in Alabama based companies. Within healthcare, GCA looks for companies in the pharmaceutical, biotechnology, medical device, and diagnostics industries. GCA prefers early and growth stage investments and generally seeks to invest between $1 to $2 million per transaction. Greer Capital Advisors was formed in 2002 and is based in Birmingham, Alabama.


Deal Context for Investor #
Overall 6 of 8
Sector: Life Science 4 of 6
Type: Venture 5 of 7
State: Alabama 3 of 5
Country: United States 6 of 8
Year: 2007 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-05-07 Aeon Bioscience

Birmingham, Alabama, United States

Aeon Bioscience, Inc. is a developer of a drug-eluting stent, to overcome the current concerns of late stent thrombosis, or blood clot formation at or near the site of the stent and vessel closure due to formation of scar tissue, known as restenosis. Aeon Bioscience was founded in 2007 and is based in Birmingham, Alabama.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-07-24 Cumberland Pharmaceuticals

Nashville, Tennessee, United States

Cumberland Pharmaceuticals is a pharmaceutical company that acquires and develops branded prescription products primarily in the gastroenterology, critical care and infection control areas. Cumberland Pharmaceuticals was founded in 1999 and is based in Nashville, Tennessee.

Sell -